Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Gade

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patientsSajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Nature Protocols|September 18, 2015
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometryHolger Franken, Toby Mathieson, Dorothee Childs, et al.
Molecular Systems Biology|March 7, 2024
Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibitionMira L Burtscher, Stephan Gade, Martin Garrido-Rodriguez, et al.
BMC Cancer|December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingJan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Breast Cancer Research and Treatment|February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trialsCaterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Nature Medicine|July 22, 2024
Proteomic signatures improve risk prediction for common and rare diseasesJulia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancerSibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, et al.
Cell|March 20, 2018
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M Savitski, Nico Zinn, Maria Faelth-Savitski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancersCarsten Denkert, Gunter von Minckwitz, Jan C Brase, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patientsSajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Nature Protocols|September 18, 2015
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometryHolger Franken, Toby Mathieson, Dorothee Childs, et al.
Molecular Systems Biology|March 7, 2024
Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibitionMira L Burtscher, Stephan Gade, Martin Garrido-Rodriguez, et al.
BMC Cancer|December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingJan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Breast Cancer Research and Treatment|February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trialsCaterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Nature Medicine|July 22, 2024
Proteomic signatures improve risk prediction for common and rare diseasesJulia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancerSibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, et al.
Cell|March 20, 2018
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M Savitski, Nico Zinn, Maria Faelth-Savitski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancersCarsten Denkert, Gunter von Minckwitz, Jan C Brase, et al.
Pageof 3